How is the Iran war affecting India's drug exports?

The Iran war is causing disruptions in India's drug exports, leading to doubled freight costs and shipping companies avoiding Gulf routes, potentially impacting exports worth $300-500 million.

What is the impact on freight costs and shipping?

Freight costs for bulk drugs from China have doubled, and shipping lines are imposing surcharges or refusing cargo to Gulf hubs.

How are Indian pharmaceutical companies responding to the crisis?

Companies are increasing their inventory levels to manage potential delays and ensure the continuity of supply chains amidst the shipping disruptions.

Home / Business and Economy / Iran War Threatens $500M India Drug Exports

Iran War Threatens $500M India Drug Exports

6 Mar

•

Summary

Freight costs for bulk drugs from China have doubled.
Shipping lines refuse Gulf cargo, imposing surcharges.
Companies are building larger drug inventories now.

Iran War Threatens $500M India Drug Exports

India's substantial pharmaceutical exports, estimated between $300-500 million, are facing significant disruption due to the ongoing Iran war.

Freight costs for essential bulk drugs and raw materials imported from China have doubled. Additionally, many shipping lines are now refusing to transport cargo to Gulf hubs or are imposing hefty surcharges, complicating crucial logistics.

These disruptions directly impact India's pharmaceutical shipments to West Asia and the GCC region, which constitute 5-6% of the country's total drug exports. West Asia also serves as a critical transit point for exports to Western nations.

In response, pharmaceutical companies are proactively building larger inventories. This strategy aims to manage potential shipping delays and ensure the continuity of supply chains, especially as the current period represents the year-end for many businesses.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.